Publicação

Validation of the quality of life multiple myeloma module questionnaire (QLQ‐MY20) in portuguese myeloma patients

Ver documento

Detalhes bibliográficos
Resumo:Objective:The aim of this study was the validation of the European Organization for Research and Treatment of Cancer's Multiple Myeloma Module (QLQ‐MY20) in Portuguese myeloma patients. Methods: A total of 213 Portuguese patients diagnosed with multiple myeloma participated in this study and were assessed with the European Organization for Research and Treatment of Cancer's (EORTC) Questionnaire C30 (QLQ‐C30), the EORTC Multiple Myeloma Module (QLQ‐MY20), the Hospital Anxiety and Depression Scale (HADS) and the Satisfaction with Social Support Scale (SSSS). Results: The validated version includes 17 items presenting good global adjustment and good internal consistency. Overall, the Portuguese validation maintains the original model with the exception of three items that were excluded. The instrument also showed good reliability and good convergent and divergent validity. Conclusion: The Portuguese version of the EORTC Multiple Myeloma Module questionnaire seems to be a valid instrument for myeloma patients to help monitor interventions in this population focused on the promotion of quality of life.
Autores principais:Pereira, M. Graça
Outros Autores:Ferreira, Gabriela Maria Magalhães; Pereira, Marta; Faria, Sara; Bacalhau, Rosário; Monteiro, Sara; Fernandes, Bruna; Vilaça, Margarida
Assunto:Aged Anxiety Depression Female Humans Male Middle aged Multiple myeloma Personal satisfaction Portugal Reproducibility of results Social support Surveys and questionnaires Quality of life Myeloma Psychological morbidity QLQ‐MY20 Quality of life Social support Ciências Sociais::Psicologia Saúde de qualidade
Ano:2019
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Universidade do Minho
Idioma:inglês
Origem:RepositóriUM - Universidade do Minho
Descrição
Resumo:Objective:The aim of this study was the validation of the European Organization for Research and Treatment of Cancer's Multiple Myeloma Module (QLQ‐MY20) in Portuguese myeloma patients. Methods: A total of 213 Portuguese patients diagnosed with multiple myeloma participated in this study and were assessed with the European Organization for Research and Treatment of Cancer's (EORTC) Questionnaire C30 (QLQ‐C30), the EORTC Multiple Myeloma Module (QLQ‐MY20), the Hospital Anxiety and Depression Scale (HADS) and the Satisfaction with Social Support Scale (SSSS). Results: The validated version includes 17 items presenting good global adjustment and good internal consistency. Overall, the Portuguese validation maintains the original model with the exception of three items that were excluded. The instrument also showed good reliability and good convergent and divergent validity. Conclusion: The Portuguese version of the EORTC Multiple Myeloma Module questionnaire seems to be a valid instrument for myeloma patients to help monitor interventions in this population focused on the promotion of quality of life.